McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
597.17
+12.79 (2.19%)
Jan 23, 2025, 4:00 PM EST - Market closed
McKesson Revenue
McKesson had revenue of $93.65B in the quarter ending September 30, 2024, with 21.29% growth. This brings the company's revenue in the last twelve months to $330.19B, up 13.43% year-over-year. In the fiscal year ending March 31, 2024, McKesson had annual revenue of $308.95B with 11.65% growth.
Revenue (ttm)
$330.19B
Revenue Growth
+13.43%
P/S Ratio
0.23
Revenue / Employee
$6,474,255
Employees
51,000
Market Cap
75.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
Mar 31, 2020 | 231.05B | 16.73B | 7.81% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
MCK News
- 9 hours ago - McKesson's Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services - Business Wire
- 16 days ago - McKesson Amplify Empowers State Pharmacy Associations Nationwide with Advocacy Funding - Business Wire
- 23 days ago - McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses - Business Wire
- 24 days ago - McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference - Business Wire
- 6 weeks ago - 12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style - Seeking Alpha
- 7 weeks ago - McKesson Corporation (MCK) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - Jim Cramer lists 10 stocks likely to perform well in December - CNBC
- 2 months ago - McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network - Seeking Alpha